Terms: = Pancreatic cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Diagnosis
79 results:
1. PRaG 3.0 therapy for human epidermal growth factor receptor 2-positive metastatic pancreatic ductal adenocarcinoma: A case report.
Kong YH; Xu ML; Zhang JJ; Chen GQ; Hong ZH; Zhang H; Dai XX; Ma YF; Zhao XR; Zhang CY; Chen RZ; Xing PF; Zhang LY
World J Gastroenterol; 2024 Mar; 30(9):1237-1249. PubMed ID: 38577174
[TBL] [Abstract] [Full Text] [Related]
2. A case report of carcinoma of the papilla of Vater associated with a hyperplasia-dysplasia-carcinoma sequence by pancreaticobiliary maljunction.
Korai T; Kimura Y; Watanabe K; Low SK; Imamura M; Nagayama M; Kukita K; Murakami T; Kato T; Kondo Y; Kyuno D; Sugawara T; Murota A; Kawakami Y; Masaki Y; Nakase H; Takemasa I
World J Surg Oncol; 2024 Feb; 22(1):63. PubMed ID: 38389074
[TBL] [Abstract] [Full Text] [Related]
3. Immunohistochemical FAP Expression Reflects
Spektor AM; Gutjahr E; Lang M; Glatting FM; Hackert T; Pausch T; Tjaden C; Schreckenberger M; Haberkorn U; Röhrich M
J Nucl Med; 2024 Jan; 65(1):52-58. PubMed ID: 38167622
[TBL] [Abstract] [Full Text] [Related]
4. Precise Identification and Profiling of Surface Proteins of Ultra Rare Tumor Specific Extracellular Vesicle with Dynamic Quantitative Plasmonic Imaging.
Zhai C; Long J; He J; Zheng Y; Wang B; Xu J; Yang Y; Jiang L; Yu H; Ding X
ACS Nano; 2023 Sep; 17(17):16656-16667. PubMed ID: 37638659
[TBL] [Abstract] [Full Text] [Related]
5. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract] [Full Text] [Related]
6. Gastric Amphicrine Carcinoma Showing neuroendocrine and pancreatic Acinar Cell Differentiation. Lesson from a Challenging Case Opening New Perspectives in the Diagnostic Work-Up of Gastric neuroendocrine Neoplasms.
Sciarra A; Uccella S; Hiroz P; Fournier I; Soubeyran V; Finzi G; La Rosa S
Endocr Pathol; 2023 Sep; 34(3):349-357. PubMed ID: 37249796
[TBL] [Abstract] [Full Text] [Related]
7. The role of claudin 18.2 and her-2 in pancreatic cancer outcomes.
Kayikcioglu E; Yüceer RO
Medicine (Baltimore); 2023 Feb; 102(6):e32882. PubMed ID: 36820561
[TBL] [Abstract] [Full Text] [Related]
8. Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.
Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt KA; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; ; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim BG; Kim JW; Kim JH; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park SY; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; ; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ
Clin Cancer Res; 2022 Dec; 28(24):5383-5395. PubMed ID: 36222710
[TBL] [Abstract] [Full Text] [Related]
9. Prospective, Multi-Institutional, Real-Time Next-Generation Sequencing of pancreatic Cyst Fluid Reveals Diverse Genomic Alterations That Improve the Clinical Management of pancreatic Cysts.
Paniccia A; Polanco PM; Boone BA; Wald AI; McGrath K; Brand RE; Khalid A; Kubiliun N; O'Broin-Lennon AM; Park WG; Klapman J; Tharian B; Inamdar S; Fasanella K; Nasr J; Chennat J; Das R; DeWitt J; Easler JJ; Bick B; Singh H; Fairley KJ; Sarkaria S; Sawas T; Skef W; Slivka A; Tavakkoli A; Thakkar S; Kim V; Vanderveldt HD; Richardson A; Wallace MB; Brahmbhatt B; Engels M; Gabbert C; Dugum M; El-Dika S; Bhat Y; Ramrakhiani S; Bakis G; Rolshud D; Millspaugh G; Tielleman T; Schmidt C; Mansour J; Marsh W; Ongchin M; Centeno B; Monaco SE; Ohori NP; Lajara S; Thompson ED; Hruban RH; Bell PD; Smith K; Permuth JB; Vandenbussche C; Ernst W; Grupillo M; Kaya C; Hogg M; He J; Wolfgang CL; Lee KK; Zeh H; Zureikat A; Nikiforova MN; Singhi AD
Gastroenterology; 2023 Jan; 164(1):117-133.e7. PubMed ID: 36209796
[TBL] [Abstract] [Full Text] [Related]
10. Immunohistochemical analysis of a panel of cancer stem cell markers and potential therapeutic markers in pancreatic ductal adenocarcinoma.
Ali SMA; Adnan Y; Ali SM; Ahmad Z; Chawla T; Farooqui HA
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2279-2292. PubMed ID: 36066622
[TBL] [Abstract] [Full Text] [Related]
11. Prevalence of BRCA1 and BRCA2 pathogenic variants in 8627 unselected patients with breast cancer: stratification of age at diagnosis, family history and molecular subtype.
Zang F; Ding X; Chen J; Hu L; Sun J; Zhang J; Xu Y; Yao L; Xie Y
Breast Cancer Res Treat; 2022 Oct; 195(3):431-439. PubMed ID: 35974241
[TBL] [Abstract] [Full Text] [Related]
12. The Effect of her2 Status on Metaplastic Breast cancer A Propensity Score-Matched Analysis.
Hu J; Zhang Y; Dong F; Shen J; Chen H; Li L; Huang T
Front Endocrinol (Lausanne); 2022; 13():874815. PubMed ID: 35928894
[TBL] [Abstract] [Full Text] [Related]
13. Mucoepidermoid carcinoma (MEC) and adenosquamous carcinoma (ASC), the same or different entities?
White VA; Hyrcza MD; Lennerz JK; Thierauf J; Lokuhetty D; Cree IA; Indave BI
Mod Pathol; 2022 Oct; 35(10):1484-1493. PubMed ID: 35871081
[TBL] [Abstract] [Full Text] [Related]
14. Implication of erbb2 as a Predictive Tool for Survival in Patients with pancreatic cancer in Histological Studies.
Ortega MA; Pekarek L; Fraile-Martinez O; Garcia-Montero C; Saez MA; Asúnsolo A; Alvarez-Mon MA; Monserrat J; Ruiz-Llorente L; García-Honduvilla N; Albillos A; Buján J; Alvarez-Mon M; Guijarro LG
Curr Oncol; 2022 Mar; 29(4):2442-2453. PubMed ID: 35448172
[TBL] [Abstract] [Full Text] [Related]
15. Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) and their Role in the Treatment of cancer: A Review.
Unnisa A; Chettupalli AK; Hussain T; Kamal MA
Anticancer Agents Med Chem; 2022; 22(20):3370-3381. PubMed ID: 35400324
[TBL] [Abstract] [Full Text] [Related]
16. Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer.
Sivapalan L; Thorn GJ; Gadaleta E; Kocher HM; Ross-Adams H; Chelala C
BMC Cancer; 2022 Apr; 22(1):369. PubMed ID: 35392854
[TBL] [Abstract] [Full Text] [Related]
17. Mucinous cystadenocarcinoma of the breast: a new entity with broad differentials-a case report.
Kaur K; Shah A; Gandhi J; Trivedi P
J Egypt Natl Canc Inst; 2022 Feb; 34(1):9. PubMed ID: 35224708
[TBL] [Abstract] [Full Text] [Related]
18. Impacts of clinicopathological factors on efficacy of trastuzumab deruxtecan in patients with her2-positive metastatic breast cancer.
Nakajima H; Harano K; Nakai T; Kusuhara S; Nakao T; Funasaka C; Kondoh C; Matsubara N; Naito Y; Hosono A; Mitsunaga S; Ishii G; Mukohara T
Breast; 2022 Feb; 61():136-144. PubMed ID: 34999427
[TBL] [Abstract] [Full Text] [Related]
19. Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study.
Lakhani NJ; Chow LQM; Gainor JF; LoRusso P; Lee KW; Chung HC; Lee J; Bang YJ; Hodi FS; Kim WS; Santana-Davila R; Fanning P; Squifflet P; Jin F; Kuo TC; Wan HI; Pons J; Randolph SS; Messersmith WA
Lancet Oncol; 2021 Dec; 22(12):1740-1751. PubMed ID: 34793719
[TBL] [Abstract] [Full Text] [Related]
20. her2-positive adenocarcinoma arising from heterotopic pancreas tissue in the duodenum: A case report.
Hirokawa YS; Iwata T; Okugawa Y; Tanaka K; Sakurai H; Watanabe M
World J Gastroenterol; 2021 Jul; 27(28):4738-4745. PubMed ID: 34366633
[TBL] [Abstract] [Full Text] [Related]
[Next]
